CLEW Medical For Profit

CLEW is a healthcare company that provides AI-driven, FDA-cleared predictive analytics for high-acuity care. Their peer-reviewed predictive insights have been documented to be at least five times more accurate than other systems. They offer truly accurate predictions of patient deterioration, up to eight hours before patient monitoring systems would suspect, which gives hospitals and health systems the opportunity for early intervention. This leads to decreases in mortality and reductions in complications and readmissions. Early identification of patient deterioration allows caregivers time to intervene proactively, which leads to decreases in unforeseen bottlenecks, reducing length of stay, improving capacity management, and access to care. CLEW offers hospitals, healthcare systems, and intensive care units advanced clinical intelligence and patient diagnostics using AI-powered, FDA-cleared predictive analytics and proprietary critical care models. Contact_info: info@clewmed.com

Headquarters: Ramat Poleg, HaMerkaz, Israel
Last Funding Type: Series B
Last Funding Date: 2020-01-15
Employee Number: 11-50
Total Funding: 20500000.0
Founded Date: 2014-01-01
Investment Stage: N/A
Technology: Biomarker panels
Investor Type: N/A
Number Of Exists: N/A
Industry: Clinical Data Management
Funding Status: Early Stage Venture